This is because the quantification of adiponectin level in the condition of patients with dyslipidemia allows a screening of the coexistence of diastolic cardiac dysfunction, and in dynamics the peptide values allow assessment of the evolution of the disease and/or of the therapy with hypolipidemic medication. Here, ADIPOQ is linked to metabolic syndrome.